The 10 principles identify areas where regulation and research are needed to create worldwide standardization in the International Medical Device Regulators Forum, according to an Oct. 27 news release.
Here are three of the guidelines:
- Study participants and data sets represent the patient population.
Protocols for data collection should mandate that relevant characteristics of the intended patient population are represented in clinical studies and datasets. Doing so helps to ensure that the results from studies are useful to the population of interest, such as age group, ethnicity or gender. - Training data sets and test sets are independent.
Training and test sets need to be independent of one another. All potential sources of dependence, such as patient, site factors and data acquisition, need to be considered and addressed to ensure independence. - Place focus on human-AI team performance.
When an AI model requires human interaction, human factors and human interpretability need to be addressed on the performance of the human and AI team, rather than how the model performs in isolation.
To read the full list of guidelines, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
